ACAN基因变异致矮身材基因改变与临床观察
Gene Mutation and Its Clinical Observation of Short Stature Caused by ACAN Gene Mutation
DOI: 10.12677/ACM.2021.114220, PDF,  被引量   
作者: 马建英:青岛大学附属青岛市海慈医院小儿内科,山东 青岛;王媛媛:潍坊市妇幼保健院儿二科,山东 潍坊;李 堂*:青岛大学附属青岛市妇女儿童医院内分泌科,山东 青岛
关键词: ACAN基因矮身材骨龄提前生长激素ACAN Gene Short Stature Advanced Bone Age Growth Hormone
摘要: 目的:分析ACAN基因变异与矮身材的关系,观察重组人生长激素(rhGH)的疗效与安全性。方法:回顾分析一例ACAN基因变异的矮身材患儿的临床资料,检索相关文献,总结ACAN基因变异与矮身材的关系,观察rhGH的疗效与安全性。结果:患儿为5岁7个月的女孩,矮身材,身高104.7 cm (−2.22 SD),其父亲身高175 cm (+0.42 SD),母亲身高163 cm (+0.47 SD),家族中均无矮身材者;无特殊面容及骨骼畸形,无第二性征发育;骨龄示7岁;基因测序示ACAN基因存在杂合变异c534C > G (p.N178K),其父母该位点均无变异,其为自发突变。予rhGH 50 ug∙kg−1∙d−1治疗,身高第一年增长7.8 cm (112.5 cm, −1.58 SD),后予rhGH 60 ug∙kg−1∙d−1治疗8个月,身高增长4.9 cm (117.4 cm, −1.28 SD),身高由−2.22SD追至−1.28 SD;骨龄进展2.5岁。结论:骨龄提前的矮身材患儿应考虑存在ACAN基因突变;应用rhGH治疗身高明显改善。
Abstract: Objective: To analyze the relationship between ACAN gene variation and short stature and observe the efficacy and safety of recombinant human growth hormone (rhGH). Methods: Review the clinical data of a case of idiopathic short stature with ACAN gene mutation and search the relevant literatures to summarize the relationship between ACAN gene mutation and short stature, and observe the efficacy and safety of recombinant human growth hormone. Results: The patient was a 5-year and 7 months old girl with a short stature of 104.7 cm (−2.22 SD). She had short stature and was 104.7 cm (−2.22 SD) in height. Her father was 175 cm (+0.42 SD) in height and her mother was 163 cm (+0.47 SD) in height .There was no short stature in her family. There was no special face and skeletal deformity and secondary sexual development. Her bone age was 7 years. The gene sequencing revealed a heterozygous variation (c534c > G (p.n178k)) in ACAN gene, which was spontaneous mutation. And there was no mutation in this locus of the ACAN gene in her parents. Her height increased by 7.8 cm (112.5 cm, −1.28 SD) in the first year of treatment with rhGH (50 ug∙kg−1∙d−1) and the height increased by 4.9 cm (117.4 cm, −1.28SD) after 8 months of treatment with rhGH (60 ug∙kg−1∙d−1). Her height recovered from −2.22 SD to −1.28 SD and her bone age progressed by 2.5 years. Conclusion: The ACAN gene mutation should be considered in children with advanced bone age and the height can be improved significantly by rhGH.
文章引用:马建英, 王媛媛, 李堂. ACAN基因变异致矮身材基因改变与临床观察[J]. 临床医学进展, 2021, 11(4): 1537-1543. https://doi.org/10.12677/ACM.2021.114220

参考文献

[1] 中华医学会儿科学分会内分泌遗传代谢学组, 中华儿科杂志编辑委员会. 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46(6): 428-430.
[2] Cohen, P., Rogol, A.D., Deal, C.L., et al. (2008) Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. The Journal of Clinical Endocrinology & Metabolism, 93, 4210-4217. [Google Scholar] [CrossRef] [PubMed]
[3] Hauer, N.N., Sticht, H., Boppudi, S., et al. (2017) Genetic Screening Confirms Heterozygous Mutations in ACAN as a Major Cause of Idiopathic Short Stature. Scientific Reports, 7, Article No. 12225. [Google Scholar] [CrossRef] [PubMed]
[4] Roughley, P.J. and Mort, J.S. (2014) The Role of Aggrecan in Normal and Osteoarthritic Cartilage. Journal of Experimental Orthopaedics, 1, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
[5] Baron, J., Sävendahl, L., De Luca, F., et al. (2015) Short and Tall Stature: A New Paradigm Emerges. Nature Reviews Endocrinology, 11, 735-746. [Google Scholar] [CrossRef] [PubMed]
[6] Lauing, K.L., Cortes, M., Domowicz, M.S., et al. (2014) Aggrecan Is Required for Growth Plate Cytoarchitecture and Differentiation. Developmental Biology, 396, 224-236. [Google Scholar] [CrossRef] [PubMed]
[7] Gkourogianni, A., Andrew, M., Tyzinski, L., et al. (2017) Clinical Characterization of Patients with Autosomal Dominant Short Stature Due to Aggrecan Mutations. The Journal of Clinical Endocrinology & Metabolism, 102, 460-469. [Google Scholar] [CrossRef] [PubMed]
[8] Gleghorn, L., Ramesar, R., Beighton, P., et al. (2005) A Mutation in the Variable Repeat Region of the Aggrecan Gene (AGC1) Causes a Form of Spondyloepiphyseal Dysplasia Associated with Severe, Premature Osteoarthritis. American Journal of Human Genetics, 77, 484-490. [Google Scholar] [CrossRef] [PubMed]
[9] Tompson, S.W., Merriman, B., Funari, V.A., et al. (2009) A Recessive Skeletal Dysplasia, SEMD Aggrecan Type, Results from a Missense Mutation Affecting the C-Type Lectin Domain of Aggrecan. American Journal of Human Genetics, 84, 72-79. [Google Scholar] [CrossRef] [PubMed]
[10] Nilsson, O., Guo, M.H., Dunbar, N., Popovic, J., et al. (2014) Short Stature, Accelerated Bone Maturation, and Early Growth Cessation Due to Heterozygous Aggrecan Mutations. The Journal of Clinical Endocrinology & Metabolism, 99, E1510-E1508. [Google Scholar] [CrossRef] [PubMed]
[11] Domowicz, M.S., Cortes, M., Henry, J.G. and Schwartz, N.B. (2009) Aggrecan Modulation of Growth Plate Morphogenesis. Developmental Biology, 329, 242-257. [Google Scholar] [CrossRef] [PubMed]
[12] Tatsi, C., Gkourogianni, A., Mohnike, K., et al. (2017) Aggrecan Mutations in Nonfamilial Short Stature and Short Stature without Accelerated Skeletal Maturation. Journal of the Endocrine Society, 1, 1006-1011. [Google Scholar] [CrossRef] [PubMed]
[13] Hattori, A., Katoh-Fukui, Y., Nakamura, A., et al. (2017) Next Generation Sequencing-Based Mutation Screening of 86 Patients with Idiopathic Short Stature. Endocrine Journal, 64, 947-954. [Google Scholar] [CrossRef
[14] Xu, D., Sun, C., Zhou, Z., et al. (2018) Novel Aggrecan Variant, p. Gln2364Pro, Causes Severe Familial Nonsyndromic Adult Short Stature and Poor Growth Hormone Response in Chinese Children. BMC Medical Genetics, 19, 79. [Google Scholar] [CrossRef] [PubMed]
[15] van der Steen, M., Pfundt, R., Maas, S.J., et al. (2017) ACAN Gene Mutations in Short Children Born SGA and Response to Growth Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 102, 1458-1467. [Google Scholar] [CrossRef] [PubMed]
[16] Lin, L., Li, M., Luo, J., Li, P., et al. (2021) A High Proportion of Novel ACAN Mutations and Their Prevalence in a Large Cohort of Chinese Short Stature Children. The Journal of Clinical Endocrinology & Metabolism, 2, dgab088. [Google Scholar] [CrossRef] [PubMed]